NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure;Hipertensión y valores de NT-proBNP. Su importacia en el diagnóstico de insuficiencia cardíaca

Revista Espanola de Cardiologia

Volumn 57, Issue 5, 2004, Pages 396-402

  Rivera Ortero, Miguel ^a,g   Taléns Visconti, Raquel ^a   Salvador, Antonio ^b   Bertomeu, Vicente ^c   Miró, Vincente ^a   García de Burgos, Fernando ^d   Climent, Vincente ^e   Cortés, Raquel ^a   Payá, Rafael ^f   Peréz Boscá, José L ^f   Mainar, Luis ^b   Jordán, Alejandro ^d   Sogorb, Francisco ^e   Cosín, Juan ^a   Mora, Vicente ^b   Diago, José L ^g   Marín, Francisco ^e  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^g Hospital Requena ^*

Author keywords

Heart failure; Hypertensi; NT proBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; COMMUNITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PATIENT REFERRAL; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RANDOMIZATION; SPAIN; STATISTICAL SIGNIFICANCE; SYSTOLE;

EID: 2942731557     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13061117     Document Type: Article

References (26)

1. Remme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
2. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88.
3. Groenning BA, Nilsson JC, Sondergaard L, Pedersen F, Trawinski J, Baumann M, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002;143:923-9.
4. Cho Y, Somer BG, Amatya A. Natriuretic peptides and their therapeutic potential. Heart Dis 1999;1:305-28.
5. Cosín Aguilar J, Hernándiz Martínez A, Díez Gil JL, Capdevila Carbonell C, Salvador Sanz A, Diago Torrent JL, et al. Valor del nivel de NTproBNP en población adulta extrahospitalaria. Rev Esp Cardiol 2003;56:236-44.
6. Osca J, Quesada A, Arnau MA, Osa A, Hervás I, Almenar L, et al. Péptido cerebral natriurético. Valor diagnó stico en la insuficiencia cardíaca. Rev Esp Cardiol 2002;55:7-15.
7. Basile J. Hypertension in the elderly: a review of the importance of systolic blood pressure elevation. J Clin Hypertens (Greenwich) 2002;4:108-19.
8. Zoccali C, Mallamaci F, Tripepi G. Hypertension as a cardiovascular risk factor in end-stage renal failure. Curr Hypertens Rep 2002;4:381-6.
9. 9 World Health Organization-Intemational Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-83.
10. Pries AR, Secomb TW. Structural adaptation of microvascular networks and development of hypertension. Microcirculation 2002;9:305-14.
11. Cosin J, Asin E, Marrugat J, Elosua R, Aros F, De los Reyes M, et al. Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol 1999;15:323-30.
12. Karl J, Borgya A, Gallusser A, Huber E, Krueger K, Rollinger W, et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 1999;230:177-81.
13. García MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75.
14. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002;288:1252-9.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
16. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-9.
17. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
18. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J Card Fail 2000;6:130-9.
19. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
20. Pieske B, Herrmann-Lingen C, Von Lewinski D, Sander J, Schenker W, Wiesenthal T, et al. NT-pro brain natriuretic peptide as marker for severity and prognosis of left ventricular dysfunction [abstract]. Circulation 2002;106:683.
21. Dahlof B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, et al, for the REGAAL Study Investigators. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 2002;20:1855-64.
22. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996;27:1753-60.
23. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with ≪isolated≫ diastolic heart failure and diastolic dysfunction. Circulation 2002;105:1195-201.
24. Brookes CI, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997;6:608-12.
25. Gerber IL, Stewart RAH, French R, Legget ME, Greaves SC, Sutton M et al. Natriuretic peptides are elevated in aortic regurgitation but correlate poorly with disease severity. J Am Coll Cardiol 2002;350B:4094.
26. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS-Kent, 1988; p. 417-57.